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Local-circuit Modulation in the Dentate Gyrus Induced by Increased 
Norepinephrine Following Orexin-A Infusion into the Locus Coeruleus 
The present thesis was designed to probe the local-circuit effects in the dentate gyrus 
following orexin-A infusion in or near the locus coeruleus as a manipulation to 
transiently increase norepinephrine levels. The study evaluated excitation and inhibition 
in the dentate gyrus as reflected in closely spaced pairs of perforant path evoked 
potentials in urethane-anesthetized rats. A paired pulse perforant path stimulation 
paradigm using three interstimulus intervals, in conjunction with a frequency dependent 
inhibition test, was used to probe local-circuit activity for early inhibition, facilitation and 
late inhibition. Measures of both the conditioning and test perforant path evoked 
potential excitatory post-synaptic potential (EPSP) slope and population spike amplitude 
were taken. 
Orexin-A infusion, in or near the locus coeruleus, resulted in a gradually developing, 
significant enhancement of population spike amplitude and EPSP slope. Based a 
comparison of input-output data taken to prior to orexin-A infusion there were no 
differences in early GABA-A mediated inhibition or in midrange facilitation effects. The 
input-output data, however, supported an increase in late, GABA-B mediated inhibition 
following locus coeruleus activation. This was the first demonstration of a possible 
noradrenergic-induced enhancement oflate paired pulse inhibition. 
Frequency dependent inhibition results were disparate; interpreting the between group 
measures suggested that frequency dependent inhibition was reduced, whereas more 
sensitive within group measures were consistent with no change. 
The increase of GABA-B mediated late inhibition initiated by norepinephrine may 
contribute to the ability of norepinephrine to reduce epileptic seizures and supports its 
role in promoting theta activity. Increased theta power has been implicated in learning 
and memory and would be consistent with norepinephrine's role in promoting plasticity. 
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1. Introduction 
The present thesis is concerned with modulation of local circuits in the dentate 
gyrus by the release of norepinephrine (NE) and in relation to long-term potentiation 
(L TP) triggered by NE. A reasonably large body of work exists describing the changes in 
the initial response to perforant path input produced by NE application or release in the 
dentate gyrus (e.g., Harley and Milway, 1986). However, relatively little work has been 
done examining NE's modulation of local-circuit effects, although in other brain areas 
NE has been reported to enhance GABAergic inhibition (Han et al., 2002), as well as 
glutamatergic actions. 
A novel technique is used here to promote NE release, the infusion of the 
excitatory peptide orexin-A into the locus coeruleus. Orexin-A has previously been 
shown to tonically excite locus coeruleus neurons and to produce NE-dependent 
potentiation of the perforant path evoked potential for hours following infusion (Walling, 
2004). Earlier results from our laboratory demonstrate that the increase in hippocampal 
NE produced by this method is transient and no longer evident 20 minutes after orexin 
infusion (Walling, 2004). Thus, both direct NE-dependent effects on local-circuit 
responses (within 20 minutes of infusion) and NE-LTP associated effects (at later time 
points) can be evaluated. 
This introduction reviews the anatomy of the dentate gyrus, its advantages for 
electrophysiological studies, the anatomy and actions of the locus coeruleus-NE system 
and the paired pulse paradigms used here to probe local-circuit actions. 
1.1 Anatomy of the Dentate Gyrus 
The principle cells of the dentate gyrus are the granule cells. The dentate gyrus 
consists of three layers: the molecular layer (inner and outer), the cell layer, and the 
polymorphic region or hilus (Amaral and Witter, 1989). 
The molecular layer consists of dendritic trees on which the perforant path and other 
terminals synapse. This layer is relatively cell free. The molecular layer is mainly 
occupied by the dendrites of granule, basket, and various polymorphic cells as well as 
terminal axonal arbors from several sources. 
The granule cell layer is the most obvious in transverse section; it consists of densely 
packed columnar stacks of cell bodies, which form aU-shape or V-shape band depending 
on antero-posterior position. The arms of the U are termed the dorsal and ventral blades 
of the dentate gyrus. The granule cells send axons, the mossy fibers, into the hilus where 
they collateralize and then form synapses with the pyramidal cells of the CA3 region 
(Buhl et al., 1994). The granule cell has a characteristic cone-shaped tree of spiny 
dendrites with all of the branches directed towards the superficial portion of the 
molecular layer. Along the deep surface of the granule cell layer, basket cells with 
pyramidal shaped cell bodies are located between the granule cell and polymorphic 
layers. The majority ofthese cells are GABA-ergic and many are immunoreactive for 
other substances such as the calcium binding protein parvalbumin. Within the same 
region occupied by the basket cells are several other cell types with markedly different 
somal shapes and dendritic arrangements. Some of these are multipolar while others are 
more fusiform shaped. These cells have several aspiny dendrites entering the molecular 
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and polymorphic layers. It seems that all of these cells supply axons that contribute to 
the basket plexus in the granule cell layer. Many of these neurons are immunoreactive 
for GABA and are acting in large part as inhibitory intemeurons (Buhl et al., 1994). 
Thus, there is a morphologically heterogeneous population of cells within, or slightly 
below, the granule cell layer that are intemeurons and many contribute to the basket 
plexus surrounding the granule cells. However, there are also cells in this subgranular 
region that do not send their axons into the granule cell layer. 
Between the dorsal and ventral blades is the polymorphic layer or hilus. The 
polymorphic cell layer is composed of a variety of neuronal cell types. The most 
common is the mossy cell. The cell bodies are large and are often triangular or 
multipolar in shape. Three or more thick dendrites originate from the cell body and 
extend for long distances within the hilus; often a dendrite will also extend through the 
granule cell layer and into the molecular layer. The mossy cell dendrites in effect never 
leave the confines of the polymorphic layer to enter the adjacent CA3 field. The most 
distinctive feature of the mossy cell is that all of the proximal dendrites are covered by 
very large and complex spines called "thorny excrescences" that are the sites of 
termination of the mossy fiber axons (Steward, 1976). The neurons in the hilus give rise 
to at least two intrinsic systems (Witter, 1993). One system, which originates in 
somatostatin and GABA-positive neurons, and apparently exerts an inhibitory effect, 
distributes to the outer two-thirds of the molecular layer. The other pathway, which 
arises from excitatory glutamatergic neurons, distributes preferentially to the inner one 
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third of the molecular layer and terminates densely at all other levels along the 
longitudinal axis of the dentate gyrus. 
The intemeurons form a local network in the dentate gyrus and function as 
neuromodulatory cells. Intemeurons of the dentate gyrus may exert inhibitory influence 
upon their target cells (the granule cells) or they may inhibit other intemeurons resulting 
in net excitatory influence on the target cells. 
The granule cells give rise to distinct unmyelinated axons called mossy fibers. The 
mossy fiber terminals in the polymorphic layer establish contacts with the proximal 
dendrites of the mossy cells, the basal dendrites ofthe pyramidal basket cells, and other 
unidentified cells (Patton and McNaughton, 1995). 
Overall, there appears to be at least three ways of providing inhibitory control over the 
excitatory granule cells (Amaral and Witter, 1995). There are a variety ofbasket cells 
located close to the granule cell layer, which contribute to the very dense terminal plexus 
that is restricted to the granule cell layer. The terminals in this basket cell plexus are 
GABA-ergic and form symmetric, presumably inhibitory contacts primarily on the cell 
bodies and shafts of apical dendrites of the granule cells. There is mounting evidence 
that GABA-ergic neurons in the polymorphic layer are themselves innervated by GABA-
ergic terminals (e.g. Misgled and Frotscher, 1986). Given the extent a single basket cell 
plexus extends, it is conceivable that a single basket cell influences a very large number 
of granule cells. A second inhibitory input to granule cells originates from the axo-
axonic or chandelier cells located in the molecular layer. These form symmetric contacts 
exclusively with the axons of granule cells. 
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There is a population of somatostatin immunopositive neurons scattered throughout the 
polymorphic layer. A dense plexus of immunoreactive fibers and terminals are also 
present in the outer two thirds of the molecular layer. The somatostatin cells located in 
the hilus, which co localize with GABA, are the main source of this plexus of fibers and 
terminals in the molecular layer (Katona et al., 1999). This system of fibers, which forms 
contacts on the distal dendrites of the granule cells, provide a third means for inhibitory 
control of granule cell activity. 
The inner third of the molecular layer receives projections that originate exclusively 
from cells in the polymorphic layer; this projection is called the associational/ 
commissural projection (Amaral and Witter, 1995). The majority of terminals of this 
pathway form asymmetric, presumably excitatory, synaptic terminals on spines ofthe 
granule cell dendrites. Many of the axons contributing to these synaptic terminals appear 
to originate from the large mossy cells of the polymorphic layer. Because the mossy cells 
are immunoreactive for glutamate, it is likely that they release this excitatory transmitter 
at their terminals within the associational/commissural zone of the molecular layer 
(Patton and McNaughton, 1995). Associational fibers, in addition to contacting the 
spines of dentate granule cells, also contact the dendritic shafts of GABA-ergic basket 
cells. Therefore, the associational and commissural projections may operate as both a 
feed-forward excitatory pathway as well as a disynaptic feed-forward inhibitory pathway. 
It appears that the mossy fiber collaterals terminating on GADA/somatostatin cells in the 
polymorphic layer may lead predominantly to direct inhibition of granule cells at the 
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same septotemporallevel and to either inhibition or excitation at more distant levels of 
the dentate gyrus. 
The dentate gyrus is the "traditional" target of entorhinal-hippocampal fibers. In the 
molecular layer of the dentate gyrus, the perforant path terminals are confined to the 
outer two thirds as asymmetric synapses (Jones, 1993). Most of these synapses occur on 
the dendritic spines of granule cells, although a small portion of parvalbumin/GABA-
positive neurons also synapse with perforant path fibers. Within the outer two thirds of 
the molecular layer, perforant path synapses make up at least 85% of the total synaptic 
population (Jones, 1993). 
Fibers that originate in the lateral entrorhinal area terminate in the outer one third of 
the molecular layer, and fibers from the medial entorhinal area terminate in the middle 
one third of the molecular layer (Abraham and McNaughton, 1984). The perforant path 
can be divided into three components: lateral, intermediate and medial. The intermediate 
pathway is thought to terminate in the molecular layer in between projections from the 
medial and lateral entorhinal areas. The lateral and medial components of the perforant 
path distribute their fibers differentially along the transverse axis of the dentate gyrus. 
The lateral perforant path projects preferentially to the suprapyramidal blade of the 
dentate gyrus, while the medial component either does not show a preference or 
predominantly targets the infrapyramidal blade. Lomo (1971) observed that with a 
stimulating electrode placed in the medial portion of the perforant path, close to the 
hippocampal fissure where the perforant path enters the dentate area, the incoming 
perforant path fibers divide the dentate area into a series of parallel segments. Andersen 
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( 1971) emphasized that the positioning of the stimulating electrode was critical when 
recording in the dentate gyrus. When the perforant path was stimulated more 
laterocaudally, closer to the angular bundle, activation of the dentate gyrus was more 
widespread. The perforant path is believed to be glutamatergic, and therefore excitatory. 
There are no cells in the dentate gyrus that project back to the entorhinal cortex. 
The hippocampus and dentate gyrus are known to have a remarkable capability for 
neuronal plasticity (Harley, 1991). When a stimulus is applied to the principle cells of 
the hippocampus two changes can occur: the cells are excited by the incoming impulse 
and if certain conditions are met permanent functional transformations can arise in the 
system of neurons. The permanent changes are referred to as plasticity. Chemical 
synapses have the capacity for short-term physiological changes, lasting seconds to a few 
hours, which increase or decrease the effectiveness of the synapse; this is referred to as 
short-term plasticity. Long term changes, lasting days or longer, can give rise to 
anatomical changes, including pruning of preexisting connections or even growth of new 
connections; this is referred to as long term plasticity. Anatomical alterations are 
typically long term and consist of the growth of new synaptic connections between 
neurons. The hippocampus displays evidence of both short and long term plasticity. 
When a new skill is learned or a new memory formed, something in the brain is changed 
in order to encode that memory. The hippocampus has been implicated as a target that is 
integral to the formation of new memories because groups of neurons in the hippocampus 
show plasticity of synaptic strength. Synaptic strength or efficacy refers to the 
effectiveness of presynaptic cell activity in inducing postsynaptic cell firing. 
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1.2 Measurement of Synaptic Efficacy 
The regular and parallel arrangement of hippocampal neurons is an auspicious 
occurrence for the electrophysiologist, as it is possible to generate large extracellular 
responses via stimulation of excitatory afferents (Barnes, 1988). It is relatively easy to 
record extracellularly from a population of dentate gyrus granule cells because of the 
tightly packed nature of these cells. Technically, it is much easier to record a 
hippocampal field potential than to record the electrical activity of individual cells, 
moreover, the former provides a picture of how cell populations respond to stimuli. 
After placing a stimulating electrode in the perforant path, a response in the millivolt 
range can be recorded in the dentate gyrus. This response is a measure of the excitability 
of a population of granule cells in the area of the recording electrode. The elicited 
response is referred to as an evoked field potential, or simply an evoked potential. In the 
dentate gyrus both the population EPSP and the population spike are revealed in the 
evoked potential resulting from perforant path stimulation. 
The EPSP is a measure of the magnitude of synaptic efficacy; as stimulation is 
increased more transmitter is released and the magnitude of the EPSP increases 
accordingly. The EPSP is a measure of current flow into the dendrites of the postsynaptic 
cells in the area of the recording electrode. Factors that influence the EPSP are the 
number of perforant path fibers activated by stimulation, the amount of neurotransmitter 
released, and the sensitivity and number ofpostsynaptic receptors (Lomo, 1971). The 
placement of the recording electrode within the dentate gyrus influences the resulting 
response. If a recording is made from the molecular layer (dendrites) the EPSP is a 
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negative going wave reflecting an inward current flow. Further downward movement of 
the recording electrode places it in the granule cell layer (cell bodies), and the evoked 
potential reverses, which reflects an outward current flow as a positive going wave. 
When the magnitude of the EPSP passes threshold, granule cell action potentials 
occur. The population spike, the other constituent of the evoked potential, is a measure 
of the number of postsynaptic cells that fire. The synchrony of granule cell firing near 
granule cell bodies appears as a negative deflection overlying the positive going EPSP. 
1.3 Modulation of Hippocampal Neuronal Transmission 
Neuronal excitability and transmission through the hippocampal formation are 
modulated by sensory input and behavioral state. For example, Herreras et al. (1988) 
found that the dentate gyrus responses to perforant path stimulation were enhanced when 
the animal had its fur stroked. Cellular excitability was also increased as judged by a left 
shifting of the EPSP-population spike relationship. Responses within area CAl exhibited 
quite different reactions. Sensory stimulation produced a dramatic decrease in both EPSP 
and population spike amplitude. The decrease in EPSP induced by sensory stimulation 
completely accounted for the reduction in population spike amplitude, as indicated by a 
lack of variation in EPSP-population spike relationship. Results demonstrate that sensory 
stimulation causes a modification of information transfer through the hippocampus. The 
alteration ofhippocampal transmission can serve to gate the information reaching CAl 
and dentate gyrus. 
Various types of anesthesia are known to affect evoked potentials in the dentate gyrus. 
For example, Shirasaka and Wasterlain (1995) examined the effects of urethane 
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anesthesia. Urethane is a commonly used anesthetic in physiological and 
pharmacological studies of animal central nervous system. Urethane has been noted to 
decrease several measures of central nervous system activity, including decreased 
spontaneous firing rates in the hippocampus (Mercer et al., 1978). Using an input-output 
paradigm Shirasaka and Wasterlain demonstrated that at lower stimulus intensities 
population spike amplitude and EPSP slope were significantly lower in urethane-
anesthetized animals compared to awake animals; these differences disappeared at higher 
stimulus intensities. It seems that urethane is either suppressing excitatory neuronal 
activity in dentate granule cells pre- or post-synaptically, or urethane is directly or 
indirectly affecting the GABAergic inhibitory system. 
Maroun and Richter-Levin (2002) have illustrated an age-related change in local-
circuit plasticity within dentate gyrus granule cells. Using several different methods they 
were able to demonstrate an age-related impairment in both population spike amplitude 
and EPSP slope: young animals (4-8 months) had significantly higher measures than old 
animals (22-28 months). However, population spike/EPSP ratios did not differ between 
groups, indicating there was no difference in the excitability of dentate granule cells. 
Using frequency dependent inhibition as a measure oflocal-circuit plasticity they showed 
that aged rats did not exhibit any reduction in frequency dependent inhibition following 
theta burst stimulation while young rats did. Both group showed similar long-term 
potentiation to theta burst stimulation. Based on this outcome they suggest changes in 
local-circuit plasticity, as reflected in frequency dependent inhibition, may be important 
for memory processes that are impaired in aged rats. 
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1.4 The Locus Coeruleus is a Source of Norepinephrine 
The major supply ofNE to the hippocampus, as well as to other brain areas, is the 
nucleus located in the pons known as the locus coeruleus (Loy et al., 1980). The locus 
coeruleus is a small dense group ofNE containing cell bodies whose projections account 
for the majority ofNE input to the hippocampal formation. Locus coeruleus axons reach 
the hippocampus via three distinct routes: the ventral amygdaloid pathway, the fornix, 
and the cingular bundle (Loy et al., 1980). Fibers from these routes innervate the dentate 
gyrus in a distinct dorsal to ventral pattern. Fibers from the locus coeruleus form the 
dorsal noradrenergic bundle before linking with the medial forebrain bundle and then 
entering the hippocampus. The hilar region of the dentate gyrus receives the densest 
projections from the locus coeruleus; however, there are less dense projections to the 
molecular and granule cells layers. The highly clustered appearance of locus coeruleus 
neurons reinforces the idea that these cells would be activated in unison and the output 
would be relatively synchronous. 
Harley and Milway (1986) demonstrated that glutamate injected into the locus 
coeruleus induced a significant increase in amplitude of the perforant path-evoked 
population spike in the dentate gyrus. It was suggested that glutamate injection into the 
locus coeruleus specifically mimicked normal physiological locus coeruleus activation, 
increasing the release ofNE in the dentate gyrus. Further support for this is illustrated in 
Harley's previous studies (e.g., Neuman and Harley, 1983), which demonstrated that NE, 
iontophoresed in the dentate gyrus at the cell body layer, produced similar increases in 
the population spike amplitude. 
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In the awake animal the level of locus coeruleus firing is a direct function of arousal. 
Cells fire the slowest during sleep and increase to higher levels with alert arousal (Aston-
Jones and Bloom, 1981), which is likely when an animal would learn or form a memory. 
Sara et al. (1994) used recordings of single unit activity in the locus coeruleus during 
learning, during spontaneous exploration of a novel environment and unfamiliar objects 
and during the presentation of auditory stimuli to illustrate that locus coeruleus neurons 
respond to novel stimuli, habituate rapidly, and respond again when the stimulus changes 
its predictive value, well before noticeable responding at a behavioral level. These 
results provide support for the suggestion that the noradrenergic system is implicated in 
shifting attention to vitally important environmental conditions. In awake animals, any 
behaviorally arousing stimulus results in a phasic increase of firing in the locus coeruleus. 
The firing rate ofNE cells is highly dependent upon behavioral state, sensory input from 
all modalities and changes of significance of environmental stimuli. Aston-Jones and 
Bloom ( 1981 ), through a series of experiments, were able to demonstrate that, although 
NE positive locus coeruleus neurons discharge in a slow tonic manner overall, mean rates 
change significantly as a function of the naturally occurring sleep wake cycle. Tonic 
discharges were highest during waking, slower during slow-wave sleep, and were nearly 
absent preceding and throughout paradoxical sleep. Aston-Jones and Bloom were also 
able to demonstrate fluctuation in locus coeruleus NE activity during certain waking 
behaviors. For example, during grooming or consuming sweet water discharges were 
decreased, while the locus coeruleus exhibited bursts of discharges during orienting 
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responses to stimuli. This again is consistent with the role of the locus coeruleus as an 
attention shifter. 
1.5 Exogenous and Endogenous Norepinephrine and Neuromodulatory Actions 
1. 5.1 Exogenous Norepinephrine 
Initially, NE was classified as an inhibitory neurotransmitter. Segal and Bloom (1976) 
observed generalized inhibitory responses in hippocampal neurons in response to 
noradrenergic stimulation and showed that activation of the locus coeruleus induced 
similar responses. However, others have provided evidence for a facilitatory role ofNE 
in that it enhances the signal to noise ratio in the neocortex and cerebellum by 
suppressing spontaneous activity of neurons and enhancing the activity evoked by 
sensory stimuli (e.g., Hasselmo, 1995). Both iontophoretic application ofNE (Neuman 
and Harley, 1983) and locus coeruleus stimulation (Harley et al., 1989) have been shown 
to potentiate population spike amplitude within the dentate gyrus. A neuromodulatory 
effect ofNE has been reported in the limbic system (see Harley, 1987 for review), which 
suggests that NE is involved in modulation of arousal and stimulation. 
In an in vitro experiment conducted by Lacaille and Harley (1985), superfusion of 10 
J.!M NE enhanced population spike amplitude and EPSP slope, and decreased onset 
latency of the population spike. These results are similar to other in vitro studies (Stanton 
and Sarvey, 1987). However, the effect ofNE on EPSP slope could not account for the 
increased population spike amplitude also produced by NE in the same slice. This 
indicates that NE produces an increase in cell responsiveness to synaptic inputs. 
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In contrast, Neuman and Harley (1983) did not observe a consistent change in EPSP 
slope, which is typically the case in vivo. Using iontophoretically applied NE a long 
lasting potentiation of the granule cell population spike was observed. It seems that NE 
alters the coupling between EPSP and population spike generation, which brings a larger 
number of cells to threshold rather than simply potentiating excitatory synaptic drive. 
Although not specifically altering synaptic strength, these results suggest NE does induce 
long-term changes in hippocampal responsivity. 
1.5.2 Endogenous Release ofNE 
Endogenous release ofNE from locus coeruleus projections in the hippocampus can 
also induce potentiation of the perforant path evoked potential in the dentate gyrus. 
Stimulation of locus coeruleus neurons results in endogenous release ofNE. 
An enhancement in perforant path induced population spike amplitude and a reduction 
in population spike onset latency can be produced by several methods of activating locus 
coeruleus neurons, including electrical stimulation, injection of glutamate, orexin-A or 
normal saline (e.g., Harley et al., 1989; Harley and Evans, 1988). Transient increases in 
population spike amplitude can also be produced by mechanical stimulation of the locus 
coeruleus (personal observation). 
Dahl and Winson (1985) varied perforant path and locus coeruleus stimulation while 
recording in the dentate gyrus. Locus coeruleus stimulation prior to perforant path 
stimulation resulted in a decrease in EPSP slope, an amplification of population spike 
amplitude and a decrease in onset latency of the population spike. These changes were 
recorded at the granule cell layer, while no changes were detected at the molecular layer. 
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Thus, the effects of locus coeruleus stimulation on EPSP may depend on the recording 
electrode position in the dentate gyrus. 
Harley et al. (1989) electrically stimulated the locus coeruleus while stimulating either 
the ipsilateral or contralateral perforant path. A pipette electrode assembly was also used 
to inject glutamate into the locus coeruleus. During ipsilateral perforant path stimulation 
an increase in population spike amplitude was seen following the offset of electrical locus 
coeruleus stimulation. The effects on EPSP slope and population spike onset latency 
were variable. Pairing locus coeruleus stimulation with contralateral perforant path 
activation also potentiated the population spike amplitude as measured in the 
contralateral dentate gyrus during locus coeruleus stimulation, albeit to a lesser extent 
than ipsilateral stimulation. It should be noted that propranolol, a beta-adrenoceptor 
blocker, had no effect on population spike potentiation produced by electrical stimulation 
of the locus coeruleus, but blocked the potentiation associated with glutamate 
stimulation. It appears that there is a separate system that can be activated in the vicinity 
of the locus coeruleus, which is capable of potentiating evoked potentials in the dentate 
gyrus, but is not dependent on beta-receptor activation. Both short and long-term 
potentiation produced by exogenous NE and by glutamate activation of the locus 
coeruleus have been shown to be critically dependent on the activation of beta-receptors 
(Harley et al., 1989). 
Harley and Evans (1988) reported that glutamate injections into the locus coeruleus 
produced a significant enhancement of the population spike that occurred within 90 
seconds of injection. EPSP slope was significantly increased, although the effects were 
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typically briefer than effects on population spike amplitude. Population spike onset 
latency, in contrast, was generally unaffected by locus coeruleus activation. Injections of 
saline into the dentate gyrus had no effect on population spike, EPSP slope or onset 
latency. However, injections oftimolol or propranolol into the dentate gyrus prior to 
glutamate injections into the locus coeruleus blocked the potentiation, and decreased 
population spike amplitude in response to locus coeruleus activation. Thus, most of the 
potentiating effects ofNE in the dentate gyrus appear to be mediated by beta-
adrenoceptors, while alpha-adrenoceptors may mediate decreased responsivity. 
More recently the orexins have been used to stimulate the locus coeruleus. Hagan et 
al. (1999) revealed an exceptionally dense innervation of orexin-A immunoreactive fibers 
and varicosities in extrahypothalamic areas, particularly the locus coeruleus. 
Furthermore, concentrations of orexin-A ranging from 30 nM to 3 !JM were shown to 
increase the rate of firing of locus coeruleus neurons. Orexin-A induced enhancement of 
locus coeruleus neuronal firing highlights one route for involvement of the peptide in 
maintaining the waking state, as cells in this area are maximally active during arousal but 
are virtually dormant during rapid eye movement sleep (Aston-Jones and Bloom, 1981). 
Both orexin-A and-Bare believed to play a broad regulatory role in the central nervous 
system and possibly regulate arousal, hormonal control, appetite and other functions 
(Hagan et al., 1999). Horvath et al. (1999) demonstrated that hypocretin (orexin-A) 
provides a large synaptic input to both the rodent and primate noradrenergic neurons in 
the locus coeruleus. 
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1.6 Paired Pulse Paradigm 
Evoking two perforant path potentials in rapid succession reveals a change in the 
response to the second pulse (P2) relative to the response to the first pulse (P1). P1 is 
referred to as the conditioning pulse and P2 as the test pulse (Steward, 1976). The 
conditioning pulse allows for the measurement of the excitatory response of the granule 
cells, while concurrently activating the local hippocampal interneuronal network. 
Observing the test pulse allows for the examination of the modulatory effect the local 
network has on the excitatory response. The differences in the resultant response are 
dependent on the interval between conditioning and test pulses, called the interstimulus 
interval (DiScenna and Teyler, 1994). 
With an interstimulus interval of 10-40 msec, P2 is smaller than P 1; this is referred to 
as early onset paired pulse inhibition (Burdette and Gilbert, 1995). The second evoked 
response is strongly inhibited when stimulation of the perforant path is spaced at this 
interval. The second response is less strongly inhibited with interstimulus intervals of 
300-1000 msec; this is referred to as late onset paired pulse inhibition (Blaise and 
Bronzino, 2000). Both types of paired pulse inhibition are believed to be mediated by 
both feed-forward and feedback mechanisms (Sloviter, 1991). DiScenna and Teyler 
(1994) were able to show that early inhibition is GABAA-mediated while late inhibition 
is GABAB-mediated. 
At interstimulus intervals of 40-200 msec P2 is larger than P 1. This is called paired 
pulse facilitation and is thought to result from a selective increase in NMDA-mediated 
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synaptic response to the second stimulation (Joy and Albertson, 1993). Paired pulse 
facilitation may also influence feed-forward inhibition. 
The level of inhibition or facilitation produced with these interstimulus intervals varies 
depending on whether the medial or lateral perforant path is being stimulated. According 
to the results of Rich-Bennett et al. ( 1993) the levels of early and late inhibition recorded 
are lower when stimulating the medial perforant path, whereas the level of facilitation is 
increased, when compared to levels of inhibition or facilitation recorded while 
stimulating the lateral perforant path. These effects are intensified with the use of 
GABAA antagonists or GABAB agonists. 
DiScenna and Teyler (1994) set out to determine the stage of growth at which 
inhibition and facilitation develop. They found that by postnatal day 6, the day at which 
a population spike could be evoked, paired-pulse effects on granule cell discharge 
indicated the presence of weak early onset inhibition. By postnatal days 7/8 the level of 
inhibition was equal to that of a mature animal. Late onset inhibition was equivalent to a 
mature animal by postnatal day 6. The most consistent difference between the mature 
and developing dentate gyrus occurred at interstimulus intervals that should produce 
population spike facilitation, where it was significantly depressed in developmental 
groups, until after the third postnatal week when was it equal to mature animals. This 
study indicated that short-term plasticity matures rapidly in the dentate gyrus and that the 
inhibitory circuitry can function at a very early age. 
Blaise and Bronzino (2000) also examined the development of the paired pulse 
response. They found significantly less early and late inhibition and facilitation in 
18 
developing animals compared to mature animals. However, a major difference in 
methodology might explain these differences, as Blaise and Bronzino utilized in vivo 
procedures, while DiScenna and Teyler utilized in vitro procedures. The differences may 
reflect the consequences of having extra-hippocampal connections removed in in vitro 
preparations. The findings ofBlaise and Bronzino are most likely due to modulation of 
local-circuit inhibitory interneuronal activity by extra-hippocampal inputs such as the 
noradrenergic projections from the locus coeruleus. The functionality of systems 
responsible for modulation of dentate granule cell excitability appears to depend on age. 
Blaise and Bronzino also examined vigilance and its effects on paired pulse responses. 
While differences in the paired pulse index did occur during quiet waking, slow-wave 
sleep, and REM sleep, there was no significant effect of vigilance state on early 
inhibition, facilitation or late inhibition. 
1. 7 Frequency Dependent Inhibition 
Frequency dependent inhibition is an additional method of examining local-circuit 
modulation within the dentate gyrus. Sloviter (1991) was one of the first to examine 
frequency dependent inhibition as a method of evaluating feed-forward and feedback 
inhibition in the hippocampus. With frequency stimulation at 0.1 Hz, paired pulses 
delivered 40 msec apart evoke no inhibition of the spike despite the fact that the first 
granule cell population spike is large. Recurrent inhibition is evident at an interstimulus 
interval of 20 msec, but it is weak. With frequency stimulation delivered at 1.0 Hz, the 
first spike paradoxically decreases in amplitude; this is frequency dependent first spike 
inhibition. Despite this decrease in first spike amplitude, inhibition of the second spike is 
19 
increased, that is the second spike is smaller at 1.0 Hz than at 0.1 Hz. The relatively 
weak inhibition evoked by stimulus pairs delivered at low frequencies is primarily 
recurrent inhibition, which is defined as the inhibition initiated by granule cell discharges. 
As afferent stimulus frequency is increased from 0.1 Hz to 1. 0 Hz, both feed forward 
inhibition and the effectiveness of paired pulse inhibition is increased, while the 
amplitude of the first spike decreases. 
Rosenblum et al. (1999) took Sloviter's ground breaking work one step further and 
examined frequency dependent inhibition within the dentate gyrus by increasing 
perforant path stimulation from 0.1 Hz to 1.0 Hz for a short interval. Sloviter (1991) was 
able to demonstrate that frequency dependent inhibition is GABA-mediated and reflects 
mainly feed-forward inhibition by perforant path activated intemeurons contacting 
dentate gyrus granule cells. Using the modified frequency dependent inhibition 
procedure, Rosenblum et al. (1999) revealed that frequency dependent inhibition in the 
dentate gyrus is NMDA dependent. After application ofMK-801, an NMDA blocker, the 
level of population spike amplitude inhibition was dramatically reduced; in contrast, the 
NMDA antagonist did not affect the frequency dependent inhibition of the EPSP slope. 
The results of this study suggest that NMDA receptor mediated currents contribute to the 
basal level responses of inhibitory intemeurons. Frequency dependent inhibition requires 
activity ofNMDA receptors. 
Furthermore, Maroun and Richter-Levin (2002) were able to demonstrate that 
frequency dependent inhibition is compromised in aged animals. This reduction in 
frequency dependent inhibition may be a reflection of a loss of local-circuit plasticity in 
20 
aged animals. Aging is associated with memory impairments and with a loss of 
intemeurons. The age-related impairment in local-circuit plasticity may be the 
consequence of the loss of intemeurons. 
1.8 The Present Study 
The purpose of the current study was to study the modulatory effects ofNE in the 
dentate gyrus of the hippocampus. The specific goals were to: 
1.) investigate potentiation of the dentate gyrus population spike with the infusion of 
orexin-A into the locus coeruleus; 
2.) examine the paired pulse paradigm within dentate gyrus granule cell circuitry; 
3.) utilize frequency dependent inhibition as a method of examining local-circuit 
plasticity within the dentate gyrus; 
4.) assess the effects of locus coeruleus activation on paired pulse responses and on 
measures of local-circuit plasticity in the dentate gyrus. 
The study evaluated the effects ofNE on excitation and inhibition of the perforant 
path evoked potential by using the administration of orexin-A to increase NE levels in the 
hippocampus and by using the paired pulse paradigm and frequency dependent inhibition 
to probe local-circuit activity. 
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2. Methods 
2.1 Subjects 
Subjects were 12 male Sprague-Dawley rats (Memorial University Vivarium) 
weighing 250-350g. Animals were provided food and water ad lib. The experimental 
protocol conformed to the IACC/CCAC guidelines. Each animal was anesthetized with 
urethane (1.5g/kg i.p.) and placed skull-flat in a stereotaxic frame. Supplemental doses 
of urethane (10% initial dose) were given at 30-minute intervals following the first 
injection if animals continued to respond to foot pinch. No animal required more than 2 
supplements. Core body temperature was maintained at 37±1 °C using a rectal probe 
coupled to a heating pad and temperature control unit. Small holes were drilled in the 
skull at points referenced from bregma to accommodate electrodes in the dentate gyrus 
and perforant pathway, and a cannula in the locus coeruleus. 
2.2 Orexin-A Preparation 
Orexin-A was prepared to concentrations of 1, 10 and 100 nM in 0.9% sterile saline. 
Initially, 500 JlL of orexin-A was stored in polypropylene containers; following 
determination of a storage container problem the peptide was stored in glass autosampler 
vials. The prepared orxin-A was stored in a -20°C freezer. The peptide was used within 
eight weeks of preparation. 
2.3 Electrode Placements 
A bipolar stimulating electrode (Rhodes NE 1 00) was placed in the perforant path of 
the left hemisphere (7.2 mm posterior, 4.0 mm lateral from bregma). A stainless steel 
unipolar electrode was directed at the cell body layer or the hilus of the dentate gyrus (3.5 
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mm posterior and 2.0 mm lateral from bregma). The depth ofthe electrode was 
optimized by monitoring the population spike recorded from the dentate gyrus as a 
response to a single square wave monophasic stimulus delivered through the perforant 
path. The recording electrode was positioned to attain a maximum size population spike; 
optimal depths ranged between 2.5 and 3.5 mm. The optimized population spike size 
ranged between 3 and 6 mV. An outer guide cannula (22 gauge) was directed at the LC 
at a zoo angle (12.6 mm posterior and 1.3 lateral to bregma and 3.6 mm ventral from skull 
surface); an inner cannula (28 gauge) extended an additional 2.4 mm beyond the guide 
cannula. 
2.4 Stimulation and Recording of Evoked Potentials 
The 'Workbench' program in the commercial electrophysiology software package 
'Brainwave' (Datawave Technologies) was used to control the stimulation and recording 
parameters in the experiment. Two monophasic 0.2 milliseconds pulses with 
interstimulus intervals of20, 100 and 500 milliseconds, to generate paired pulse early 
inhibition, facilitation, and late inhibition, respectively, were generated by a Datawave 
AID board and delivered through a constant current unit at a frequency of 0.1 Hz. Two 
samples of each paired pulse measure were thus taken every minute. Signals were 
amplified 50x-200x using a bandpass setting ofO.l-3.0 KHz by a Grass preamplifier and 
displayed on a dual channel digital oscilloscope. Waveforms were digitized on-line at a 
rate of 10,000 points/second, displayed on a computer monitor and stored using 
Brainwave and a personal computer. 
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2.5 Experimental Protocol 
For each subject stimulating electrodes were lowered first. Then, animals received 
single pulse stimulation typically at 400-600 flA current as recording electrodes were 
lowered to approximate depths of2.5-3.5 mm below brain surface until maximal 
negative-going population spikes with latencies of 5 milliseconds or less were obtained. 
First, a baseline measure was collected using a single pulse stimulation of 400-600 
flA. 
Second, an input-output curve was obtained using interleaved paired pulses (with 
interstimulus intervals to induce early inhibition, facilitation, and late inhibition), 
beginning at a current of 16 flA and then proceeding on a scale to 1260 flA (16, 32, 64, 
100, 250, 500, 750, 1000, and 1260 f.!A). Three interstimulus intervals were executed 
one after another with a 10 sec delay between each paired pulse. Every 30 seconds 
current was increased until the series was completed from 16-1260 flA. This procedure 
was repeated until 6 complete input-output sets were completed. 
In the third step, stimulation was adjusted to achieve a 50% population spike on Pl. A 
frequency dependent inhibition probe was then employed. This consisted of ten pulses at 
0.1 Hz followed by ten pulses at 1.0 Hz; this was repeated twice. 
In the fourth step, using the previously obtained 50% population spike current a 30 
minute baseline period was recorded using the three interleaved paired pulses. 
The fifth step was at the end of the baseline period. Using a Hamilton syringe, 200 nl 
of a 1 nM or a 100 nM solution of orexin-A (California Peptide) was injected into the 
locus coeruleus for a two minute period. 
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The interleaved paired pulses were continued for an additional30 minutes as the sixth 
step. 
The seventh step included a post-orexin-A input-output curve that used the same 
current values and time intervals as used in the pre-drug input-output curve. 
In the final and eighth step, the frequency dependent inhibition probe was repeated. 
This was followed by frequency dependent inhibition probes with the current reduced to 
match the population spike to its pre-orexin-A amplitude. 
The experimental protocol is illustrated below. 
• 
t t t t t t t 
P1 Baseline Pre orexin·A Pre orexln-A Pre orexin·A Orexln-A Post orexin·A Post orexin·A Post orexln-A 
Input output FDI paired pulse Infusion paired pulse Input output FDI paired pulse baseline baseline paired pulse 
paradigm paradigm 
2.6 Histology 
Immediately after the recording procedure the subject was removed from the 
stereotaxic apparatus and decapitated with a guillotine. Within 1 0 minutes of sacrifice, 
the brain was removed and frozen in approximately 20 mL of 2-methyl butane that had 
been previously cooled in a -80°C freezer for at least 20 minutes. Brains were stored in 
the same freezer until sectioning. 
For verification of electrode and cannula placement, brains were cut into 40 11m 
sections on a Jung Frigocut cryostat microtome and placed on glass microscope slides. 
Sections were then subjected to an acetylcholinesterase metachromatic Nissl staining 
procedure. During sectioning alternate slices were subjected to active and total glycogen 
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phosphorylase staining procedure to facilitate localization of the stainless steel recording 
electrode. Slides were then analyzed using a projecting microscope. 
2. 7 Evoked Potential Parameter Extraction 
For each animal the parameter extraction option in the 'Workbench' program was 
used to measure the population spike amplitude and EPSP slope. Measurement #25 
(Peak to Valley) from the 'Electrophysiology' function set was used to obtain population 
spike amplitude while measurement # 1 was used to determine EPSP slope. 
2.8 Statistical Analysis 
Five minute averages were analyzed using a repeated measures ANOV A to compare 
pre vs. post orexin-A population spike and EPSP slope for Pl, P2, and P2/Pl ratios. A 
post hoc Duncan multiple range analysis with p<0.05 was performed when the repeated 
measures ANOV A proved significant. 
Using the input-output curve data, sets with similar pre and post PI values were 
selected to match the PI measures and test the change in paired pulse ratios when PI was 
matched. P2/P I ratios for each of the paired pulses were averaged to get an average ratio 
for each condition with a matched PI value. Repeated measures t-tests were then 
performed on the P2/P I ratio values (e.g., pre PI 500 ~-tamp vs. post PI 250 ~-tamp) to 
obtain measures of facilitation and inhibition. 
Correlations between EPSP slope and population spike were examined pre and post 
orexin-A. Correlations between the paired pulse ratios and their associated Pl population 
spikes and EPSP slopes were also examined. For completeness, a correlational analysis 
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ofP1 population spike amplitude to P2/P1 EPSP slope for each of the paired pulse 
measures was conducted. 
For frequency dependent inhibition, the population spike amplitude or EPSP slope of 
responses 2-4 at 0.1 Hz was averaged and compared with that of the averaged last 3 
responses at 1.0 Hz in each set. The results ofthe 2 sets were averaged. This procedure 
follows that of Rosenblum et al. ( 1999). Paired t-tests were used to compare percent 
inhibition produced by frequency dependent inhibition pre and post orexin-A. 
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3. Results 
3.1 General 
Two of the 12 animals were excluded from the analysis because of unexplained 
changes in the evoked potential parameters. The remaining 10 animals were divided into 
two groups. The experimental group consisted of four animals that had significant 
enhancement of P 1 population spike amplitude characteristic of noradrenergic 
modulation in the dentate gyrus. All of these animals had injection tip placements in or 
within 200 microns of the locus coeruleus (Figure 1a). Orexin-A for these animals was 
also stored in appropriate glass containers. The experimental animals received a 100 nM 
concentration of orexin-A. The control group consisted of 6 animals that did not have 
any significant increase in PI population spike amplitude post-injection; the sixth step as 
outlined in the methods section. Two had injection sites outside of the locus coeruleus 
(Figure 1 b), these animals received a 100 nM concentration of orexin-A; while four had 
accurate site placement but were assumed to have inadequate levels of orexin due to 
storage of the peptide in polypropylene to which is adheres (Kastin and Akerstrom, 
1999). Two of these animals received a 1 nM concentration of orexin-A (11C and 12 C), 
while the other two animals received a 100 nM concentration of orexin-A (13C and 14C). 
Previous work showed that both 1 and 100 nM concentrations of orexin-A produced NE 
induced potentiation of the population spike in the dentate gyrus. The orexin-A given to 
the control animals with accurate site placement in the locus coeruleus, perforant path 
and dentate gyrus was assumed to be inactivate because no population spike potentiation 
was observed. In addition, several other researchers in the laboratory using orexin-A 
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stored in polypropylene containers did not observe population spike potentiation when 
accurate site placement was used. When orexin-A was stored in the appropriate glass 
autosampler vials population spike potentiation was observed when accurate electrode 
and injection tip site placements were employed. 
3.2 Effect of Orexin-A on the Response to the First Pulse (Pl) 
3.2.1 Experimental Group 
Mean baseline population spike amplitude for the experimental group (n=4) was 3.06 
mV (±1.43); mean post orexin-A population spike amplitude was 3.73 mV (±1.77) for an 
average increase to 122% of baseline. Mean baseline EPSP slope for the experimental 
group was 4.19 mV/ms (±1.62); mean post orexin-A EPSP slope was 4.30 mV/ms 
(±1.69). Here the average increase was 103% ofbaseline. 
Figure 2 illustrates the P 1 normalized population spike amplitude for the experimental 
group; P1 potentials following orexin-A infusion were normalized to P1 potentials 
following orexin-A infusion. The repeated measures ANOV A revealed that P 1 
population spike amplitude significantly increased over time (F 11 ,33=9.58; p<0.05). 
Duncan post-hoc comparisons at p=0.05 showed that PI population spike amplitude 
increased at the point of orexin-A injection and continued to increase (up to 26% over 
baseline) over the 30 minutes post injection period for the experimental group. 
Figure 3 shows the P1 normalized EPSP slope for the experimental group. The 
repeated measures ANOV A revealed that P 1 EPSP slope also significantly increased over 
the baseline period (F 11,33=2.64; p<0.05). Duncan post-hoc comparisons at p=0.05 
showed that P 1 EPSP slope was significantly greater than baseline at 10 minutes post 
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orexin-A and consistently larger from 20 minutes out, until the end of the post injection 
period with a final percentage increase of 8%. 
A correlational analysis was conducted to determine the relationship between P 1 
EPSP slope and P 1 population spike amplitude. Table 1 shows the results of this analysis 
for the experimental group. During the baseline period for two of four animals there was 
no correlation between EPSP slope and population spike amplitude; post orexin-A there 
was a significant negative correlation suggesting increased cell excitability. Larger 
population spikes occurred with smaller EPSPs. For the other two experimental animals 
there was a significant positive correlation between population spike amplitude and EPSP 
slope both during the baseline and post orexin-A injection. For these animals the 
correlations increased once the norepinephrine system was activated by orexin-A. 
3.2.2 Control Group 
As noted there were no differences pre and post injection in population spike 
amplitude for the control group. Mean baseline population spike amplitude for this group 
was 2.58 mV (±0.37); post injection population spike amplitude was 2.53 mV (±0.38). 
The control group EPSP slope also did not differ pre and post injection. Mean baseline 
EPSP slope for the control group was 3.27 m V/ms (±0.36); mean post injection EPSP 
slope was 3.20 mV/ms (±0.38). 
Figure 2 illustrates the PI normalized population spike amplitude for the control 
group. 
Table 2 illustrates the results of the EPSP slope - population spike amplitude 
correlational analysis for the control group. No strong pattern or relationship between 
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these two measures was seen for this condition. During the baseline period three of 6 
control animals showed a positive correlation between EPSP slope and population spike 
amplitude; after the orexin-A injection only one of the 6 animals maintained this positive 
correlation. 
3.3 Effect of Orexin-A on the Response to the Second Pulse (P2) 
3.3.1 Effect of Orexin-A on Experimental Group P2 Potential 
A repeated measures ANOV A was performed on P2 potentials to determine whether 
the effects of orexin-A are similar to the effects on PI potentials. This analysis was 
conducted with the P2's for each of the three respective paired pulse conditions. For the 
early inhibition paired pulse for the experimental group, the repeated measures ANOV A 
revealed the P2 population spike amplitude tended to decrease post orexin-A compared to 
baseline (F 11,33=2.06; p<0.05). The P2 population spike decreased over the 30 minute 
post injection period. The facilitation paired pulse P2 population spike amplitude tended 
to increase, but this was not significant (F 11 ,33=1.85; ns). Finally, the P2 associated with 
late inhibition showed a significant increase (F 11 ,33=2.56; p<O.OS). Duncan post-hoc 
comparisons at p=O.OS showed that P2 population spike amplitude increased at the point 
of injection and continued to increase until the end of the post injection period with a 
final percentage increase of approximately 22%, a similar pattern to that of P 1 overall. It 
appears then that orexin-A increased the P2 population spike outside of the early 
inhibition window. 
Repeated measures ANOVA were also conducted on P2 EPSP slope for each of the 
paired pulses. None of these individual analyses were significant for the experimental 
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group. However, across all of the paired pulse conditions, there was a trend for P2 EPSP 
slope to increase over the 30 minute post orexin-A injection period as did P1 EPSP slope 
(Fll,33=1.56; ns). 
3.3.2 Effect of Orexin-A on Control Group P2 Potential 
Repeated measures ANOV A conducted on P2 population spike amplitude for the 
control group revealed no significant difference pre and post orexin-A for the early 
inhibition P2 or the facilitation P2 potentials (F 11,33=0.30, ns; and F 11,33 = 1.84, ns, 
respectively). The late inhibition P2 decreased significantly in the control group but the 
decrease appeared to be an anomaly as it began 15 minutes prior to injection (F 11,33 =3 .82; 
p< 0.05). 
For the control group, the repeated measures ANOVA for P2 EPSP slope associated 
with early inhibition (F11,33=2.21; p<0.05) and facilitation (Fll,33=3.27; p<0.05) revealed 
a decrease over time. The P2 EPSP slope associated with late inhibition did not change. 
The repeated measures ANOV A for late inhibition was not significant for P2 EPSP slope 
(F11,33=I.I2; ns). It seems that in the control group, as with P2 population spike 
amplitude, P2 EPSP slope decreased over time without any experimental manipulation. 
3.4 Effect of Orexin-A on Input-output Relations 
3.4.1 Experimental Group 
Figure 4 illustrates the change in P 1 population spike amplitude over the range of 
input-output current values for the experimental group. At all currents with a measurable 
population spike, population spike amplitudes are larger following orexin-A activation of 
the norepinephrine system than before this activation. Figure 5 presents the variation in 
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Pl EPSP slope over the extent of input-output current values for the experimental group. 
Again, the Pl EPSP slopes are larger following the orexin-A injection; however, they are 
not of the magnitude of the increase in Pl population spike. 
Based on Figure 4, Pl population spikes were selected for the experimental group 
that had similar amplitudes prior to and following orexin-A injections. This required 
using population spikes at different currents. P2/P1 ratios were then compared at these 
current levels. Current values that were selected were 500 J!amp pre injection and 250 
J!amp post injection. The mean P1 population spike amplitude at 500 J!amp prior to 
injection was 1.94 mV (±0.19); the mean P1 population spike amplitude at 250 J!amp 
following the injection was 1.49 m V (±0.33). The difference between these means was 
not significant (t3=2.42, ns). 
3.4.2 Control Group 
Control group input-output curves for population spike and EPSP slope did not 
change (Figures 8 and 9). Since current changes were not needed to match population 
spikes, for the parallel analyses 500 J!amp was chosen to compare pre- post values. The 
mean P1 population spike amplitude at 500 J!amp prior to injection was 1.63 mV 
(±0.074); the mean P1 population spike amplitude at 500 J!amp following the injection 
was 1.61 mV (±0.095). As expected the difference between these means was not 
significant (ts=0.22, ns). 
3.4.3 Effect of Orexin-A on Paired Pulse Index 
Significant negative Pl to P2/Pl correlations (p<O.Ol), ranging from -0.54 to 
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-0.95 across the four experimental subjects for all paired pulse conditions, suggest that 
larger Pls are associated with smaller P2s even at intervals where inhibition is not 
predicted (i.e., facilitation) and justify the use of the PI-matching technique in the 
analysis of paired pulse measures, described in the Methods section. All population spike 
correlations for the experimental and control groups can be found in Tables 3 and 4. 
3.4.3.1 Effect of Orexin-A on Experimental Group Paired Pulse Early Inhibition 
The mean early inhibition of the population spike amplitude paired pulse ratio for 
baseline was 0.28 (±0.13) for the experimental group. Post orexin-A the early inhibition 
population spike amplitude paired pulse ratio was reduced to 0.23 (±0.10). The repeated 
measures ANOVA revealed that P2/P1 was significantly smaller post orexin-A than 
during the baseline period (F 11 ,33=3.84; p<0.05). Duncan post-hoc comparisons at p=0.05 
showed that early inhibition P2/P 1 population spike amplitude ratio was significantly 
smaller at 15 min post orexin-A and continued to decrease to approximately 0.19 at the 
end of the 30 min record (Figure 6). EPSP slope ratios during baseline and post orexin-A 
did not differ (Table 5). 
Table 3 presents the P 1 vs. early inhibition P2/P 1 correlation analysis for population 
spike for the experimental group. Prior to orexin-A, for two animals the P 1 vs. P2/P 1 for 
early inhibition population spike amplitude correlation was non-significant; the 
correlation for the other two animals during this period was negative and significant at 
p=O.O 1. For the period following orexin-A activation of the norepinephrine system 
correlations for all animals were negative and significant; this analysis indicates that, as 
P1 increased (as a result of orexin-A), there was a corresponding decrease in the early 
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inhibition ratio for population spike amplitude, meaning that there was more inhibition. 
Thus, larger P 1 population spikes were associated with increased early inhibition, as 
expected. 
For this reason input-output curve data taken initially and at the end of the 
experiments were used to compare changes in the paired pulse ratios when initial spike 
sizes were matched. See later sections 3.4.3.3 on page 38, 3.4.3.6 on page 40 and 3.4.3.9 
on page 42. 
3.4.3.2 Effect of Orexin-A on Control Group Paired Pulse Early Inhibition 
There were no significant differences in paired pulse early inhibition pre and post 
injection for the control group. Mean early inhibition population spike amplitude paired 
pulse ratio for baseline was 0.29 (±0.071) for the control group; the post orexin-A paired 
pulse ratio was 0.29 (±0.084). EPSP slope paired pulse ratios for early inhibition are 
presented in Table 5; again there was no difference between this measure pre and post 
orexin-A. 
Figure 6 shows the control group's P2/Pl early inhibition ratios for population spike 
amplitude. A repeated measures ANOV A revealed no significant differences between 
baseline and post orexin-A measures (F 11 ,33=1.60; ns). A repeated measures ANOVA for 
P2/Pl EPSP slope also showed no significant difference between baseline and post 
injection measures (Fn,33=0.87; ns). 
Table 4 presents the results of a correlational analysis of P 1 vs. P2/P 1 early inhibition 
for population spike amplitude for the control group. Prior to injection PI correlated 
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negatively with P2/P 1 in two of 6 rats; after injection three of 6 rats showed a significant 
negative correlation (Table 4). 
3.4.3.3 Effect of Orexin-A on Input-output Paired Pulse Early Inhibition Ratio 
Figure 7 illustrates the early inhibition P2/Pl population spike amplitude ratios for the 
range of input-output currents prior to and following the orexin-A injection. 
The early inhibition paired pulse ratio for population spike amplitude was compared 
using at-test at 500 !!amp pre injection and at 250 !!amp post injection for the 
experimental group. The mean P2/Pl population spike ratio at 500 !!amp was 0.25 
(±0.13) prior to injection; following the orexin-A injection the mean P2/Pl population 
spike ratio at 250 !!amp was 0.16 (±0.085). The difference between these means was not 
significant (t3=1.95, ns). This result indicates that differences in the P2/Pl ratio may be 
accounted for by the increase in the PI population spike amplitude. 
The mean P2/Pl EPSP slope ratio for the experimental group at 500 !!amp was 0.86 
(±0.07); following the orexin-A injection the P2/Pl EPSP slope ratio at 250 !!amp was 
0.87 (±0.03). The difference between these means was also not significant (t3=0.15, ns). 
The early inhibition paired pulse ratio for population spike was compared using at-
test at 500 !!amp pre injection and at 500 !!amp post injection for the control group. as 
there was no change in population spike amplitude following the injection. The mean 
P2/Pl population spike ratio prior to orexin-A injection was 0.25 (±0.08); after the 
injection the P2/Pl population spike ratio was 0.24 (±0.09). There was no significant 
difference between the pre and post measures (t5=0.32, ns). 
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The mean P2/P1 EPSP slope ratio for the control group before the injection was 0.78 
(±0.02); following the injection the P2/P1 EPSP slope ratio was 0.78 (±0.02). The 
difference between these means was not significant (t5=0.06, ns). 
3.4.3.4 Effect of Orexin-A on Experimental Group Paired Pulse Facilitation 
The mean facilitation population spike amplitude paired pulse ratio taken at 100 msec 
interstimu1us interval for baseline was 2.12 (±0.40) for the experimental group. Post 
orexin-A the facilitation population spike amplitude paired pulse ratio was reduced to 
2.09 (±0.32). The repeated measures ANOVA revealed that P2/P1 was significantly 
smaller post orexin-A than during the baseline period (Fll,33=4.74; p<O.OS). Duncan 
post-hoc comparisons at p=O.OS showed that the facilitation P2/P1 population spike 
amplitude ratio was significantly smaller at 5 min post orexin-A and continued to 
decrease to about 2.00 at the end of the 30 min record (Figure 8). Table 5 provides the 
paired pulse ratios for EPSP slope. EPSP slope ratios during baseline and post orexin-A 
did not differ greatly. 
Table 3 presents the P 1 vs. P2/P 1 correlation analysis for population spike in the 
experimental group. The P 1 population spike amplitude correlated negatively with the 
facilitation P2/P 1 ratio for all experimental animals. This analysis indicates that larger 
P 1 s were associated with less facilitation or possibly increased inhibition. However, this 
could be an artifact of a ceiling effect with larger P 1 s. 
3.4.3.5 Effect of Orexin-A on Control Group Paired Pulse Facilitation 
Mean facilitation population spike amplitude paired pulse ratio for baseline was 2.12 
(±0.21) for the control group; the post orexin-A paired pulse ratio was 2.25 (±0.23). 
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There were no significant differences in this ratio after injection. EPSP slope paired 
pulse ratios for facilitation are presented in Table 5. 
Table 4 presents the results of a correlational analysis of P 1 vs. P2/P 1 facilitation for 
population spike amplitude for the control group. Prior to injection all control animals 
had significant negative correlations for P 1 vs. P2/P 1 facilitation population spike 
amplitude; post injection 5 of 6 animals had significant negative correlations, albeit 
smaller correlations than pre measures. 
3.4.3.6 Effect of Orexin-A on Input-output Paired Pulse Facilitation Ratio 
Figure 9 illustrates the facilitation P2/P 1 population spike amplitude ratios for the 
range of input-output currents prior to and following the orexin-A injection. 
The facilitation paired pulse ratio for population spike amplitude was compared using 
at-test at 500 ~-tamp pre injection and at 250 ~-tamp post injection for the experimental 
group. The mean P2/P1 population spike ratio at 500 ~-tamp was 1.97 (±0.21) prior to 
injection; following the orexin-A injection the mean P2/P1 population spike ratio at 250 
~-tamp was 2.35 (±0.33). The difference between these means was not significant 
(t3=1.077, ns). This result indicates that differences in the facilitation P2/Pl population 
spike amplitude ratio may be accounted for by the increase in the P 1 population spike 
amplitude. 
The mean P2/Pl EPSP slope ratio for the experimental group at 500 ~-tamp was 0.96 
(±0.02); following the orexin-A injection the P2/P1 EPSP slope ratio at 250 ~-tamp was 
0.97 (±0.02). The difference between these means was also not significant (t3=l.008, ns). 
38 
The facilitation paired pulse ratio for population spike was compared using at-test at 
500 ~-tamp pre injection and at 500 ~-tamp post injection for the control group. The mean 
P2/P1 population spike ratio prior to orexin-A injection was 1.68 (±0.09); after the 
injection the P2/P1 population spike ratio was 1.80 (±0.14). There was no significant 
difference between the pre post measures (t5=1.77, ns). 
The mean P2/P1 EPSP slope ratio for the control group before the injection was 0.93 
(±0.01); following the injection the P2/P1 EPSP slope ratio was 0.93 (±0.01). The 
difference between these means was not significant (t5=0.88, ns). 
3.4.3. 7 Effect of Orexin-A on Experimental Group Paired Pulse Late Inhibition 
The mean late inhibition population spike amplitude paired pulse ratio at 500 msec 
interstimulus interval for baseline was 0.76 (±0.02) for the experimental group. Post 
orexin-A the late inhibition population spike amplitude paired pulse ratio was reduced to 
0.72 (±0.042). The repeated measures ANOVA revealed that the P2/P1 was not 
significantly different post orexin-A than during the baseline period (F 11 ,33= 1.3 72; ns ); as 
is also seen in Figure 10. Table 5 illustrates the paired pulse ratios for EPSP slope. EPSP 
slope ratios during baseline and post orexin-A did not differ significantly. 
Table 3 presents the P1 vs. P2/Pl correlation analysis for population spike for the 
experimental group. Prior to orexin-A, three of four rats showed a significant negative 
correlation between spike amplitude and late inhibition; following orexin-A all rats 
showed a significant negative correlation. This pattern suggests that as PI increased 
there was a corresponding decrease in the late inhibition ratio for population spike 
amplitude, meaning that there was increased late inhibition. 
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3.4.3.8 Effect of Orexin-A on Control Group Paired Pulse Late Inhibition 
Mean late inhibition population spike amplitude paired pulse ratio for baseline was 
0.70 (±0.07) for the control group; the post orexin-A paired pulse ratio was 0.62 (±0.09). 
There were no significant differences in these ratios over time (Figure 1 0). EPSP slope 
paired pulse ratios for late inhibition are presented in Table 5; again there was no 
difference between this measure pre and post orexin-A injection. 
Table 4 present the results of a correlational analysis of P 1 vs. P2/P 1 late inhibition for 
population spike amplitude for the control group. Prior to injection three of 6 control 
animals had significant negative correlations for PI population spike amplitude vs. P2/Pl 
population spike amplitude ratio; post injection 5 of 6 animals had significant negative 
correlations. 
3.4.3.9 Effect of Orexin-A on Input-output Paired Pulse Late Inhibition Ratio 
Figure 11 illustrates the late inhibition P2/P 1 population spike amplitude ratios for the 
range of input-output currents prior to and following the orexin-A injection. 
The late inhibition paired pulse ratio for population spike amplitude was compared 
using at-test at 500 ~-tamp pre injection and at 250 ~-tamp post injection for the 
experimental group. The mean P2/Pl population spike ratio at 500 ~-tamp was 0.92 
(±0.07) prior to injection; following the orexin-A injection the mean P2/Pl population 
spike ratio at 250 ~-tamp was 0.68 (±0.04). The difference between these means was 
significant (t3=5.18, p<0.05). This result indicates that there is an increase in the late 
inhibition P2/Pl population spike amplitude ratio at lower currents that cannot be 
accounted for by the increase in the P 1 population spike amplitude. 
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The mean P2/P1 EPSP slope ratio for the experimental group at 500 J.!amp was 0.93 
(±0.03); following the orexin-A injection the P2/Pl EPSP slope ratio at 250 J.!amp was 
0.89 (±0.02). The difference between these means was not significant (t3=2.02, ns). 
The late inhibition paired pulse ratio for population spike was compared using at-test 
at 500 J.!amp pre injection and at 500 J.!amp post injection for the control group. The 
mean P2/Pl population spike ratio prior to orexin-A injection was 0.79 (±0.07); after the 
injection the P2/P1 population spike ratio was 0.78 (±0.05). There was no significant 
difference between the pre post measures (t5=0.25, ns). 
The mean P2/Pl EPSP slope ratio for the control group before the injection was 
0.91 (±0.02); following the injection the P2/Pl EPSP slope ratio was 0.93 (±0.01). The 
difference between these means was not significant (t5=2.37, ns). 
3.5 Frequency Dependent Inhibition 
3.5.1 Effect of Orexin-A on Experimental Group Frequency Dependent Inhibition 
Frequency dependent inhibition measures were collected approximately 35 minutes 
prior to orexin-A injection and 90 minutes following the injection. The mean 0.1 Hz 
population spike amplitude prior to the orexin-A injection for the experimental group was 
3.08 mV (±1.39); following the injection the mean 0.1 Hz population spike amplitude 
was 4.33 mV (±1.97); t3=2.14, ns. The mean EPSP slope for the experimental group was 
4.09 mV/ms (±1.57) before the orexin-A injection; following the injection the mean 
EPSP slope was 4.56 mV/ms (±1.81); t3=1.74; ns. Although not significant there was a 
40% increase in population spike amplitude for the experimental group; in addition there 
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was also an 11% increase in EPSP slope. Both of these measures are consistent with a 
slowly developing potentiation. 
The mean frequency dependent inhibition population spike amplitude ratio for the 
experimental group prior to orexin-A activation of the locus coeruleus was 0.65 (±0.04); 
following the injection the mean frequency dependent inhibition population spike 
amplitude ratio was 0.66 (±0.02). The mean frequency dependent inhibition EPSP slope 
ratio for the experimental group before orexin-A was 0.88 (±0.01); after the orexin-A 
injection the EPSP slope ratio was 0.90 (±0.04). There were no significant differences. 
For the post baseline period, a matching procedure, in which the current was 
lowered to produce a 0.1 Hz population spike amplitude similar to baseline, was 
employed to control for changes in P1 after the orexin-A injection; matched values are 
reported for population spike and EPSP slope for the post period only. The mean 
matched frequency dependent inhibition population spike ratio for the experimental 
group was 0.72 (±0.07); the mean matched frequency dependent inhibition EPSP slope 
ratio was 0.92 (±0.04). There were no differences in the frequency dependent inhibition 
ratios pre and post injection for the matched data. 
3.5.2 Effect of Orexin-A on Control Group Frequency Dependent Inhibition 
The mean 0.1 Hz population spike amplitude for the control group prior to the orexin-
A injection was 2.51 mV (±0.42); following the injection the mean population spike 
amplitude was 2.48 mV (±0.38); t5=0.19, ns. The mean 0.1 Hz EPSP slope for the 
control group prior to the orexin-A injection was 3.15 mV/ms (±0.35); the post injection 
mean EPSP slope was 3.06 mV/ms (±0.33); t5=0.19, ns. 
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The mean frequency dependent inhibition population spike amplitude ratio for the 
control group prior to the orexin-A injection was 0.61 (±0.10). Following the injection 
the frequency dependent inhibition ratio for population spike amplitude was 0.55 (±0.07). 
The mean post injection matched frequency dependent inhibition population spike 
amplitude ratio was 0.56 (±0.03); the mean frequency dependent inhibition EPSP slope 
for the control group before the orexin-A injection was 0.93 (±0.02); the mean frequency 
dependent inhibition ratio for the period following the injection was 0.94 (±0.01). The 
pre and post injection frequency dependent inhibition ratios for spike amplitude and 
EPSP slope did not differ. The difference between these two means was not significant 
(ts=0.86; ns). 
3.6 Experimental Versus Control Group Differences 
Experimental and control group population spike amplitudes, EPSP slopes and the 
various paired pulse measures were examined using two-way ANOV A. Prior to orexin-
A injection there was no significant difference between the experimental and control 
groups. The experimental group was significantly different from the control group for 
population spike amplitude at all time points following injection of orexin-A (F 1,9=5.86; 
p<0.05). There were no differences between the experimental and control groups on 
EPSP slope or any of the paired pulse measures. Using the matched post orexin-A 
frequency dependent inhibition population spike amplitude the experimental group had a 
significantly larger ratio (0.72 vs. 0.56) than the control group (tg=2.37; p<0.05); this may 
reflect an increase in feed forward inhibition in the experimental animals compared to the 
control group. The groups were not significantly different prior to the orexin-A injection. 
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The frequency dependent inhibition EPSP slope did not differ between the groups 
following orexin-A infusion. 
Differences between the experimental and control group were compared using the 
paired pulse ratios for the input output measures. While there was a trend for the late 
inhibition paired pulse ratio measures to be lower in the experimental animals following 
orexin-A, the difference did not reach statistical significance, possibly because of the 
small sample size of the experimental group. The groups did not differ on the measures 
of early inhibition or facilitation, either before or after orexin-A injection. 
3.7 Summary 
Orexin-A infusion into the locus coeruleus produced a 122% increase over baseline in 
population spike amplitude in the experimental group; larger population spikes tended to 
occur with smaller EPSPs. There were no differences in the control group. Late paired 
pulse inhibition was significantly altered in the experimental group, with both population 
spike amplitude and late inhibition P2/Pl population spike amplitude ratio being reduced 
following the orexin-A injection. While there were no detectable differences in frequency 
dependent inhibition in the experimental group following orexin-A injection as compared 
to pre-injection, this measure did indicate greater feed-forward inhibition in the 
experimental group following orexin-A injection as compared to the control group. 
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4. Discussion 
The present experiments were directed at analyzing the effects of orexin-A on 
three types of recurrent phenomena found with perforant path stimulation in that 
circuitry: ( 1) early inhibition, (2) facilitation and (3) late inhibition. The results 
replicated a previous report that orexin-A injection in or near the locus coeruleus results 
in a gradually developing, significant enhancement ofEPSP slope and population spike 
amplitude (Walling et al., 2004). The present study also demonstrated for the first time a 
possible noradrenergic enhancement of late inhibition. Contrary to earlier claims (e.g., 
Sara and Bergis, 1991 ), there was no modulation of early inhibition that could not be 
accounted for by the indirect effects of an enhanced population spike. A similar result 
was observed for facilitation. Frequency-dependent inhibition, which was probed as a 
measure ofNMDA receptor modulation, displayed mixed results. The within group 
measure suggested no change in frequency dependent inhibition, while the between group 
measure suggested frequency dependent inhibition was reduced. 
Each ofthese results will be considered in turn. 
4.1 Orexin-A Infusion in the Locus Coeruleus Replicates Noradrenergic Effects on 
the First Perforant Path Evoked Potential 
In the present study orexin-A increased the perforant path population spike to 
122% of baseline at 30 minutes post-infusion for the experimental group. The EPSP slope 
increased to 108% of baseline over the same period for the experimental group. These 
changes in response to the baseline perforant path current mediated by locus coeruleus 
activation by orexin-A were confirmed in the input-output curves compared before, and 
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after, baseline recording in which larger population spikes are seen following infusion at 
all current levels that produce spikes. Average slope in the input-output curves was also 
elevated. Control population spike amplitude and EPSP slope values were unchanged by 
using either baseline or input-output measures. Using between-group analyses, only the 
population spike amplitude following orexin-A infusion was significantly different 
between experimental and control groups indicating the robustness of the spike 
enhancement. 
Potentiation of the perforant path population spike is consistently reported with 
the application of norepinephrine in vitro (Lacaille and Harley, 1985; Stanton and Sarvey, 
1985), iontophoretically (Neuman and Harley, 1983) or through glutamatergic (Harley 
and Milway, 1986) or electrical (Babstock and Harley, 1992; Harley et al., 1989) 
activation of the locus coeruleus. Potentiation effects of 130-400% ofbaseline have been 
reported in these studies. 
In a previous study of orexin-A infusion in the locus coeruleus (Walling et al., 
2004) a similar population spike amplitude increase to the one observed here was 
observed at 30 minutes, however, with a longer recording period potentiation continued 
to develop to 155% of baseline at 3 hr post injection. A prolonged development of 
population spike potentiation appears to characterize orexin-A locus coeruleus activation 
effects on the perforant path potential and distinguishes it from the profile observed with 
glutamate activation of the locus coeruleus. With glutamate activation, spike potentiation 
reaches asymptote more rapidly and may decline from an initially higher level (Harley 
and Sara, 1992; Klukowski and Harley, 1994). 
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This difference in the development of population spike potentiation could relate to 
the profile oflocus coeruleus unit firing induced by the two methods. With orexin-A 
infusions there is a steady increase in tonic firing for a limited period on the order of 20 
minutes or less (Walling et al., 2004 ), while with glutamate there is a brief intense 
barrage of firing lasting less than 500 ms that is followed by inhibition of locus coeruleus 
firing over minutes before baseline activity resumes (Harley and Sara, 1992). Both types 
of activation produce a similar elevation of norepinephrine in the hippocampus ( ~ 200%) 
for the first microdialysis sample (20 minutes) with a return to basal norepinephrine by 
the second sample (40 minutes later) (Walling et al., 2004). 
Thus, effects on hippocampal neurophysiology with either glutamatergic or 
orexinergic activation that are seen beyond 20 minutes are not related to the continuing 
direct action of norepinephrine, but reflect norepinephrine-initiated changes in cell 
responses. During the initial 20 minutes it is likely that norepinephrine release occurs in a 
different pattern with glutamatergic and orexinergic activation, but microdialysis cannot 
resolve these temporal differences. 
Increases in EPSP slope have been variably reported with locus coeruleus 
activation (Babstock and Harley, 1992; Harley and Milway, 1986), although they are 
more consistently observed in the in vitro studies (Stanton and Sarvey, 1985). In the 
previous study of orexin-A effects (Walling et al. 2004) an early transient EPSP slope 
increase was reported, but no enduring changes were observed. Here the EPSP slope 
does show lasting change. Thus, orexinergic locus coeruleus activation also appears to 
have variable effects on EPSP slope in vivo. 
47 
The increase in EPSP slope does not account for the increase in population spike 
supporting the earlier characterization of noradrenergic effects in vivo (Munro et al., 
2001; Richter-Levin et al., 1991) and in vitro (Robinson and Racine, 1985; Sarvey et al., 
1989) as increases in the coupling of EPSP slope to spike generation or as an increase in 
cell excitability. 
4.2 Modulation of the Second Perforant Path Evoked Potential Population Spike by 
Orexin-A Infusion into the Locus Coeruleus Varies Depending on the Paired Pulse 
Interval 
If the second population spike in each paired pulse is considered alone, the second 
spikes from short interval pairs decrease after orexin-A activation of the locus coeruleus, 
whereas the second spikes at longer intervals tended to increase in amplitude. This 
pattern suggests the increased driving of the first population spike promotes greater 
feedback inhibition at short intervals despite any general potentiating effects of 
norepinephrine release. There were no significant changes in EPSP slope for any of the 
second perforant path evoked potentials in a pair, although the trend was for increases. 
The second population spikes at the intermediate facilitation interstimulus interval 
showed increases, but these increases were not significant. Second population spikes at 
the longer late inhibition interval did significantly increase over time in a degree similar 
to that of the first population spike potentiation. This could be due to general 
noradrenergic potentiation effects operating on the second population spike as well as on 
the first population spike in a pair or to a reduction in late inhibition. As discussed below 
a reduction in late inhibition does not appear to occur, but rather the converse. 
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4.3 Spike Matching Significantly Alters Apparent Changes in Evoked Potentials at 
Each of the Three Paired Pulse Intervals, but does not Affect Frequency-Dependent 
Inhibition 
Without spike matching early feedback inhibition mediated by GABA-A 
receptors (DiScenna and Teyler, 1994) appeared to increase after locus coeruleus 
activation by orexin-A as the ratio of the second population spike to the first was 
significantly smaller in the last 15 minutes post orexin-A. However, since all 
experimental subjects and half of the control subjects demonstrated a significant negative 
correlation between size of the first population spike and the P2/P 1 ratio for early 
inhibition in the baseline period, an increase in that ratio with an increase in P1 is 
expected. 
When the input-output curve relating the early inhibition ratio to current was used 
to find currents that gave matching P 1 population spike amplitudes for the experimental 
group, there was no change in the P2/P1 ratio. Thus, early inhibition, independent ofP1 
increases, was unchanged in the present study. This contrasts with the conclusion 
reached in an earlier test of feedback inhibition change with norepinephrine elevation, in 
which the alpha 2 antagonist, idazoxan, was used to elevate norepinephrine (Sara and 
Bergis, 1991 ). In this study greater feedback inhibition was reported, but only at a 25 ms 
interstimulus interval when inhibition decreased from a ratio of just over 0.6 to just under 
0.4 after norepinephrine elevation. At other interstimulus intervals, including both 
shorter intervals with more inhibition, as in the present study, and longer intervals with 
similar or less feedback inhibition, no change in inhibition was observed. The authors 
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suggest norepinephrine produced an increase in feedback inhibition unrelated to an 
increase in the first spike because in one rat the first spike did not change while the 
increased feedback inhibition at 25 ms interstimulus interval was still observed. Thus the 
authors argued for independent effects of norepinephrine on population spike potentiation 
and feedback inhibition. 
The present data are at odds with this conjecture. However, in the present study, 
the interstimulus interval used was 5 ms shorter than that which gave increased feedback 
inhibition in the Sara and Bergis study. The 20 ms interstimulus interval in the Sara and 
Bergis study produced a P2/P1 ratio of approximately 0.3 and was not changed after 
idazoxan administration. 
The difference in interstimulus interval may account for the different outcome 
between studies. The Sara and Bergis study also differed in other ways. Rats were 
unanesthetized in the Sara and Bergis study. There was no control for the size of the first 
spike in 7 of 8 rats and antagonism of alpha 2 receptors is a different mechanism of 
norepinephrine increase that may alter the effect profile. Idazoxan also affects 
imidazoline receptors (Hudson et al., 1999; Mallard et al., 1992), which could contribute 
to differences in outcomes. 
It is surprising that Sara and Bergis did not observe a difference in feedback 
inhibition at any interval other than 25 ms since the present data in both control and 
experimental rats strongly suggest that larger population spikes should recruit increased 
levels of early feedback inhibition. They had larger spikes at all intervals but increased 
inhibition at only one interval. If input/output curves had been taken and the normal 
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spike relationship to early feedback inhibition obtained, it might even be argued that their 
data show feedback inhibition at other intervals is reduced. 
Small sample size is a concern in the present study. The feedback ratio with 
matched population spikes was smaller after orexin A (0.16 versus 0.25), but this 
difference, with anN of four, was not significant. Thus, more subjects would be useful 
before drawing a final conclusion about early feedback inhibition. 
At intermediate paired pulse intervals, the normal population spike facilitation 
appeared to decrease with a smaller ratio being observed after orexin-A activation of 
locus coeruleus. For the facilitation ratio, population spike amplitude was negatively 
correlated with the facilitation ratio in experimental and control rats. So, again, to assess 
whether there is a real change in facilitation, it was necessary to control population spike 
size using input-output curve data for the facilitation ratio. There were no significant 
differences in population spike or EPSP slope facilitation ratios when amplitude of the 
first population spike was matched. 
At the longest paired pulse interval, late inhibition ratios did not change 
significantly after orexin-A infusion in the locus coeruleus. However, late inhibition 
ratios during baseline were also negatively correlated with spike size with larger spikes 
associated with greater late inhibition. Thus, even though this relationship was not 
evident in the post-orexin paired pulse baseline data, late inhibition input-output ratios 
were examined under conditions that matched the first population spike amplitude. In 
this case, when spikes were matched in amplitude, there was a clear and significant 
increase in late inhibition following orexin-A activation of the locus coeruleus. The late 
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inhibition ratio was approximately 0.9, thirty minutes prior to orexin-A infusion into the 
locus coeruleus, while the same size Pl produced a late inhibition ratio of less than 0.7, 
30 minutes after orexin-A infusion. These effects are clearest with small spikes that may 
reflect a more physiological level of granule cell activation. This pattern of results 
suggests a long-lived increase in the GABA-B mediated effects that underlie late 
inhibition (Davies and Collingridge 1993; Mott and Lewis, 1994; Stanford et al., 1995) 
after norepinephrine release in the dentate gyrus. 
Frequency-dependent inhibition is not altered when examined 30 minutes after 
orexin-A infusion into the locus coeruleus. When population spike matching was used 
for the pre and post frequency-dependent inhibition comparisons by adjusting stimulation 
current to approximate the spike size prior to orexin-A infusion, there was still no 
difference in frequency-dependent inhibition within the experimental group. With 
matching, the frequency-dependent inhibition for experimental rats after infusion of 
orexin-A was less than that seen in controls, but this may be a sampling error, since the 
more sensitive within-test did not detect a difference. 
Frequency-dependent inhibition is influenced both by GABA-A activation 
(Maroun and Richter-Levin, 2002; Sloviter, 1991) and by NMDA receptor activation 
(Rosenblum et al., 1999), so it is not surprising that this measure does not change. In the 
context of the present study GABA-A function appears unaltered by norepinephrine 
release in early feedback inhibition and there is no previous evidence for long-lasting 
changes in NMDA receptor function with norepinephrine release. Some evidence does 
suggest that there are direct norepinephrine effects on NMDA receptors (Burgard et al., 
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1989; Harley, 1991; Stanton et al., 1989), but not long-lasting ones. To test a direct 
norepinephrine influence on NMDA action, it would be necessary to examine frequency-
dependent inhibition immediately after locus coeruleus activation when norepinephrine is 
likely to be present in the target area. The lack of change in the facilitation ratio with 
matched spikes, a measure also taken after 30 minutes, also suggests no enduring effect 
on NMDA receptor function. NMDA receptor enhancement has been suggested to 
underlie paired pulse facilitation (Joy and Albertson, 1993), although there is also 
evidence for other mechanisms (Andreasen and Hablitz, 1994; Brucato et al., 1995). 
While the frequency dependent inhibition measure, and those measures that 
required the input-output curves to equate for spike amplitude were taken 30 minutes 
after locus coeruleus activation by orexin-A and are, presumably, outside the window of 
direct norepinephrine influence, the first evoked potential and the other paired pulse 
measures were taken continually from the point of orexin-A infusion into the locus 
coeruleus. There were no changes that were confined to the likely period of direct 
norepinephrine influence. The most common pattern was a gradual increase in effect 
strength with time after locus coeruleus activation suggesting most effects were initiated 
by, but not continually dependent on, norepinephrine. 
4.4 Conclusions 
In summary, an increase in GABA-B mediated late inhibition appears to be a 
second enduring effect of locus coeruleus activation in the dentate gyrus with the first 
enduring effect being that of potentiation ofthe population spike amplitude. As far as is 
known, this is the first report of enduring change in an inhibitory circuit in the dentate 
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gyrus other than in pathological conditions. Increased GABA-B inhibition might account 
for norepinephrine's ability to reduce epileptic seizures in a variety of models (Kamphuis 
et al., 1991). It would also tend to exaggerate the theta rhythm, since inhibition occurring 
~200 ms after principal cell activation would be enhanced. Such an exaggeration of 
excitatory/inhibitory cycles could contribute to the increase in theta power reported to 
occur with locus coeruleus activation (Berridge et al., 1993; Berridge and Foote, 1991). 
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6. Tables 
Table 1: Experimental group EPSP slope versus population spike correlations 
Subject Slope vs population Sign. Slope vs population Sign. 
spike pre orexin-A spike post orexin-A 
16 0.037 ns -0.261 * 
19 0.093 ns -0.355 ** 
21 0.374 ** 0.578 *** 
27 0.457 *** 0.530 *** 
Table 2: Control group EPSP slope versus population spike correlations 
Subject Slope vs population Sign. Slope vs population Sign. 
spike pre orexin-A spike post orexin-A 
11 0.499 *** -0.031 ns 
12 0.326 * 0.378 ** 
13 0.072 ns -0.211 ns 
14 0.058 ns 0.034 ns 
18 -0.014 ns -0.0354 ns 
22 0.659 *** 0.2374 ns 
Table 3: Experimental group Pl versus P2/Pl population spike correlations 
Subject EI Sign. EI Sign. FAC Sign. FAC Sign. LI Sign. LI Sign. 
pre post pre post pre post 
16 -0.849 ...... -0.850 ...... -0.956 ...... -0.954 ...... -0.580 ...... -0.642 ...... 
19 -0.348 ns -0.864 *** -0.842 *** -0.916 *** -0.661 *** -0.614 *** 
21 -0.649 *** -0.675 *** -0.926 *** -0.856 *** -0.751 *** -0.536 ** 
27 0.174 ns -0.542 ** -0.849 *** -0.634 *** -0.234 ns -0.594 *** 
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Table 4: Control group PI versus P2/PI population spike correlations 
Subject EI Sign. EI Sign. FAC Sign. FAC Sign. LI Sign. LI Sign. 
pre post pre post pre post 
11 -0.322 ns -0.559 ** -0.586 *** -0.399 * -0.229 ns -0.690 *** 
12 -0.781 *** -0.681 *** -0.944 *** -0.962 *** -0.304 ns -0.698 *** 
13 0.191 ns -0.140 ns -0.760 *** -0.127 ns -0.793 *** -0.827 ** 
14 -0.075 ns -0.202 ns -0.825 *** -0.754 *** -0.761 *** -0.274 ns 
18 -0.050 ns -0.052 ns -0.888 *** -0.883 *** -0.584 *** -0.645 *** 
22 -0.530 ** -0.552 ** -0.900 *** -0.522 ** -0.088 ns -0.664 *** 
Table 5: Average PI EPSP slope and EPSP slope paired pulse ratios for experimental and 
control groups 
Condition Pl Pl P2/Pl P2/Pl P2/Pl P2/Pl P2/Pl 
(mV/ms) (mV/ms) EI EI FAC FAC LI 
Pre Post Pre Post Pre Post Pre 
Experimental 4.193 4.302 0.914 0.894 0.955 0.961 0.913 
(± 1.621) (± 1.687) (± 0.040) (± 0.025) (± 0.016) (± 0.020) (± 0.023) 
Control 3.271 3.20 0.824 0.821 0.920 0.908 0.913 
(± 0.364) (± 0.368) (± 0.018) (± 0.019) (± 0.013) (± 0.014) (± 0.014) 
Table 6: Average PI population spike and population spike paired pulse ratios for 
experimental and control group 
Condition Pl (mV) Pl (mV) P2/Pl P2/Pl P2/Pl P2/Pl P2/Pl 
Pre Post EI EI FAC FAC LI 
Pre Post Pre Post Pre 
Experimental 3.059 3.729 0.284 0.232 2.119 2.091 0.7631 
(±1.427) (±1.772) (± 0.127) (±0.095) (± 0.401) (±0.317) (± 0.018) 
Control 2.576 2.531 0.286 0.293 2.116 2.251 0.698 
(±0.374) (±0.384) (± 0.071) (±0.084) (± 0.214) (± 0.232) (± 0.069) 
65 
P2/Pl 
LI 
Post 
0.922 
(± 0.024) 
0.921 
(± 0.014) 
P2/Pl 
LI 
Post 
0.720 
(± 0.042) 
0.617 
(± 0.089) 
7. Figures 
-100""' 
Figure la. Locus coeruleus electrode placements for the experimental group. 21E 
placement was approximately 160 Jlm lateral to the locus coeruleus (LC). 
-1001'"' 
Figure lb. Locus coeruleus electrode placements for the control group. llC, 12C, 13C 
and 14C received inactive forms of orexin-A. 18C and 22C had placements 
that were between 360 and 520 11m lateral to the locus coeruleus (LC). 
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Figure 2: PI population spike amplitude for experimental (•) and control ( ...... )groups. PI 
population spike amplitude increased at the point of orexin-A injection and 
continued to increase over the 30 minute post injection period for the 
experimental group. 
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Figure 3: PI EPSP slope for experimental (•) and control ( •) groups. PI EPSP slope 
was significantly greater than baseline at I 0 minutes post orexin-A and 
consistently larger from 20 minutes out, until the end of the post injection 
period for the experimental group. 
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Figure 4: All pre (•) vs. post ( .... ) Pl population spike amplitudes for the experimental 
group. At all currents with a measurable population spike, population spike 
amplitudes are larger following orexin-A activation of the norepinephrine 
system than before this activation. 
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Figure 5: All pre (•) vs. post ( ...... ) EPSP slope for experimental group. P 1 EPSP slopes 
are larger following the orexin-A injection; however, they are not of the 
magnitude of the increase in Pl population spike. 
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Figure 6: Early inhibition P2/P1 population spike amplitude ratio for experimental 
(•) and control ( ...... ) groups. Early inhibition P2/P 1 population spike amplitude 
ratio was significantly smaller at 15 minutes post orexin-A and continued to 
decrease to the end of the 30 minute record. 
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Figure 7: Early inhibition P2/Pl population spike amplitude ratio for input-output curves 
pre (•) and post ( •) orexin-A infusion for experimental group. Pre and post 
early inhibition measures did not differ, which indicates that differences in the 
P2/Pl ratio may be accounted for by the increase in the Pl population spike 
Amplitude. 
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Figure 8: Facilitation P2/Pl population spike amplitude ratio for experimental (•) and 
control ( •) groups. The facilitation P2/Pl population spike amplitude ratio was 
significantly smaller at 5 minutes post orexin-A and continued to decrease to the 
end ofthe 30 minute record. 
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Figure 9: Facilitation P2/P1 population spike amplitude ratio for input-output curves pre 
(•) and post ( •) orexin-A infusion for experimental group. Pre and post 
facilitation measures did not differ, which indicates that differences in the P2/P 1 
ratio may be accounted for by the increase in the P 1 population spike amplitude. 
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Figure 10: Late inhibition P2/P 1 population spike amplitude ratio for experimental (•) 
and control ( ...... ) groups. The late inhibition P2/P 1 population spike amplitude 
ratio did not differ pre and post orexin-A infusion. 
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Figure 11: Late inhibition P2/Pl population spike amplitude ratio for input-output curves 
pre (•) and post ( •) orexin-A infusion for experimental group. Pre and post 
late inhibition measures did differ, which indicates that there is an increase in 
the late inhibition P2/P 1 population spike amplitude ratio at lower currents that 
cannot be accounted for by the increase in the P 1 population spike amplitude. 
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